{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:39:22Z","timestamp":1788287962953,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-024-04803-8","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T23:56:04Z","timestamp":1736121364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predicting treatment response and survival in rectal cancer: insights from 18 FDG-PET\/MRI post-neoadjuvant therapy"],"prefix":"10.1007","volume":"40","author":[{"given":"Valentina","family":"Ferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hipolito","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Malave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ballelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Broglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Garcia","family":"Ca\u00f1amaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Verdu","family":"Segui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Perez","family":"Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"4803_CR1","unstructured":"American Cancer Society - Key statistics for colorectal cancer. cancer.org | 1.800.227.2345"},{"key":"4803_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A (2023) Colorectal cancer statistics. https:\/\/doi.org\/10.3322\/caac.21772","DOI":"10.3322\/caac.21772"},{"key":"4803_CR3","doi-asserted-by":"publisher","unstructured":"NCCN Clinical practice guidelines in oncology \u2013 rectal cancer, version 2.2022. https:\/\/doi.org\/10.6004\/jnccn.2022.0051","DOI":"10.6004\/jnccn.2022.0051"},{"key":"4803_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/bjs.10318","volume":"104","author":"S Pucciarelli","year":"2017","unstructured":"Pucciarelli S, Giandomenico F, De Paoli A et al (2017) Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer. Br J Surg 104:138\u2013147","journal-title":"Br J Surg"},{"issue":"23","key":"4803_CR5","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Guillem JG, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40(23):2546\u20132556. https:\/\/doi.org\/10.1200\/JCO.22.00032","journal-title":"J Clin Oncol"},{"key":"4803_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2019.03.016","volume":"135","author":"J Erlandsson","year":"2019","unstructured":"Erlandsson J, L\u00f6rinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, Martling A (2019) Tumour regression after radiotherapy for rectal cancer - results from the randomised Stockholm III trial. Radiother Oncol 135:178\u2013186. https:\/\/doi.org\/10.1016\/j.radonc.2019.03.016","journal-title":"Radiother Oncol"},{"issue":"5","key":"4803_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouch\u00e9 O, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, Morand C, de la Fouchardi\u00e8re C, Lamfichekh N, Juzyna B, Jouffroy-Zeller C, Rullier E, Marchal F, Gourgou S, Castan F, Borg C, Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22(5):702\u2013715. https:\/\/doi.org\/10.1016\/S1470-2045(21)00079-6","journal-title":"Lancet Oncol"},{"key":"4803_CR8","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00330-005-2658-4","volume":"15","author":"T Denecke","year":"2005","unstructured":"Denecke T, Rau B, Hoffmann KT et al (2005) Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15:1658\u20131666","journal-title":"Eur Radiol"},{"key":"4803_CR9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2214\/AJR.14.13210","volume":"204","author":"AM Maffione","year":"2015","unstructured":"Maffione AM, Marzola MC, Capirci C, Colletti PM, Rubello D (2015) Value of (18)F-FDG PET for predicting response to neoadjuvant therapy in rectal cancer: systematic review and meta-analysis. AJR Am J Roentgenol 204:1261\u20131268","journal-title":"AJR Am J Roentgenol"},{"key":"4803_CR10","doi-asserted-by":"publisher","unstructured":"Crim\u00ec F, Spolverato G, Lacognata C, Gariri M, Cecchin D, Urso ED et al F-FDG PET\/MRI for rectal cancer TNM restaging after preoperative chemoradiotherapy: initial experience. https:\/\/doi.org\/10.1097\/DCR.0000000000001568","DOI":"10.1097\/DCR.0000000000001568"},{"key":"4803_CR11","doi-asserted-by":"publisher","unstructured":"Queiroz MA, Ortega CD, Ferreira FR, Nahas SC, Cerri GG, Buchpiguel CA Diagnostic accuracy of FDG-PET\/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients. https:\/\/doi.org\/10.1007\/s00259-020-04911-x","DOI":"10.1007\/s00259-020-04911-x"},{"issue":"1","key":"4803_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00384-023-04573-9","volume":"38","author":"V Ferri","year":"2023","unstructured":"Ferri V, Vicente E, Quijano Y, Duran H, Diaz E, Fabra I, Malave L, Ruiz P, Costantini G, Pizzuti G, Cubillo A, Rubio MC, Ca\u00f1amaque LG, Alfonsel JN, Caruso R (2023) Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis. Int J Colorectal Dis 38(1):277. https:\/\/doi.org\/10.1007\/s00384-023-04573-9","journal-title":"Int J Colorectal Dis"},{"issue":"11","key":"4803_CR13","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11):2680\u20132686","journal-title":"Cancer"},{"issue":"3","key":"4803_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/DCR.0000000000001568","volume":"63","author":"F Crim\u00ec","year":"2020","unstructured":"Crim\u00ec F, Spolverato G, Lacognata C, Garieri M, Cecchin D, Urso ED, Zucchetta P, Pucciarelli S, Pomerri F (2020) 18F-FDG PET\/MRI for rectal cancer TNM restaging after preoperative chemoradiotherapy: initial experience. Dis Colon Rectum 63(3):310\u2013318. https:\/\/doi.org\/10.1097\/DCR.0000000000001568","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"4803_CR15","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00259-020-05036-x","volume":"48","author":"OA Catalano","year":"2021","unstructured":"Catalano OA, Lee SI, Parente C, Cauley C, Furtado FS, Striar R, Soricelli A, Salvatore M, Li Y, Umutlu L, Ca\u00f1amaque LG, Groshar D, Mahmood U, Blaszkowsky LS, Ryan DP, Clark JW, Wo J, Hong TS, Kunitake H, Bordeianou L, Berger D, Ricciardi R, Rosen B (2021) Improving staging of rectal cancer in the pelvis: the role of PET\/MRI. Eur J Nucl Med Mol Imaging 48(4):1235\u20131245. https:\/\/doi.org\/10.1007\/s00259-020-05036-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4803_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10151-018-1779-0","volume":"22","author":"S Ishihara","year":"2018","unstructured":"Ishihara S, Kawai K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, Morikawa T, Watanabe T (2018) Diagnostic value of FDG-PET\/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Tech Coloproctol 22:347\u2013354. https:\/\/doi.org\/10.1007\/s10151-018-1779-0","journal-title":"Tech Coloproctol"},{"issue":"3","key":"4803_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12149-021-01580-0","volume":"35","author":"F Crim\u00ec","year":"2021","unstructured":"Crim\u00ec F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, Cecchin D, Pucciarelli S (2021) [18F]FDG PET\/MRI in rectal cancer. Ann Nucl Med 35(3):281\u2013290. https:\/\/doi.org\/10.1007\/s12149-021-01580-0","journal-title":"Ann Nucl Med"},{"key":"4803_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.crad.2016.05.005","volume":"71","author":"MRS Siddiqui","year":"2016","unstructured":"Siddiqui MRS, Gormly KL, Bhoday J, Balyansikova S, Battersby NJ, Chand M et al (2016) Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol 71:854\u2013862","journal-title":"Clin Radiol"},{"key":"4803_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jss.2019.04.080","volume":"243","author":"E Sorenson","year":"2019","unstructured":"Sorenson E, Lambreton F, Yu JQ, Li T, Denlinger CS, Meyer JE, Sigurdson ER, Farma JM (2019) Impact of PET\/CT for restaging patients with locally advanced rectal cancer after neoadjuvant chemoradiation. J Surg Res 243:242\u2013248. https:\/\/doi.org\/10.1016\/j.jss.2019.04.080","journal-title":"J Surg Res"},{"issue":"9","key":"4803_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/0284186X.2019.1622774","volume":"58","author":"V Ferri","year":"2019","unstructured":"Ferri V, Vicente Lopez E, QuijanoCollazo Y, Caruso R, Duran Gimenez Rico H, Ielpo B, Diaz Reques E, Fabra Cabrera I, Malav\u00e8 Cardozo L, Isernia R, Pinna E, Plaza Hernandezv C, Garcerant M, Garcia Ca\u00f1amaques L, PerezDue\u00f1as V (2019) Quantitative analysis of 18-FDG-PET\/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study. Acta Oncol 58(9):1246\u20131249. https:\/\/doi.org\/10.1080\/0284186X.2019.1622774","journal-title":"Acta Oncol"},{"issue":"2","key":"4803_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0000000000004499","volume":"276","author":"AC Lord","year":"2022","unstructured":"Lord AC, D\u2019Souza N, Shaw A, Rokan Z, Moran B, Abulafi M, Rasheed S, Chandramohan A, Corr A, Chau I, Brown G (2022) MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann Surg 276(2):334\u2013344. https:\/\/doi.org\/10.1097\/SLA.0000000000004499","journal-title":"Ann Surg"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04803-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-024-04803-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04803-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:25:28Z","timestamp":1736137528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-024-04803-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4803"],"URL":"https:\/\/doi.org\/10.1007\/s00384-024-04803-8","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"31 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Sanchinarro Hospital. All experiments were performed in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki). Informed consent was obtained from all participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}